IntelGenx to Report Fourth Quarter and Full-Year 2017 Financial Results on March 29, 2018 – Conference Call to Follow
March 23 2018 - 4:01PM
IntelGenx Technologies Corp. (TSX VENTURE:IGX)
(OTCQX:IGXT) today announced that it will release its fourth
quarter and full year 2017 financial results after market close
on March 29, 2018.
An accompanying conference call will be hosted
by Dr. Horst G. Zerbe, President and Chief Executive Officer,
and Mr. Andre Godin, Executive Vice-President and Chief
Financial Officer, to discuss the results and provide a business
update. Details of the conference call and webcast are below:
Date: Thursday, March 29,
2018
Time: 4:30 p.m. EDT
Conference dial-in: (833)
211-3233
International
dial-in: (647) 689-3955
Conference ID: 6786519
Webcast
Registration: Click here
Following the live call, a replay will be
available on the Company's website, www.intelgenx.com, under
"Investor Relations."
About IntelGenx:
Established in 2003, IntelGenx is a leading oral
drug delivery company primarily focused on the development and
manufacturing of innovative pharmaceutical oral films based on its
proprietary VersaFilm™ technology platform.
IntelGenx's highly skilled team provides
comprehensive pharmaceuticals services to pharmaceutical partners,
including R&D, analytical method development, clinical
monitoring, IP and regulatory services. IntelGenx's
state-of-the-art manufacturing facility, established for the
VersaFilm™ technology platform, supports lab-scale to pilot and
commercial-scale production, offering full service capabilities to
its clients. More information about the company can be found at
www.intelgenx.com.
Each of the TSX Venture Exchange and OTCQX has
neither approved nor disapproved the contents of this press
release. Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Source: IntelGenx Technologies Corp.
For more information, please contact:
Stephen Kilmer
Investor Relations
(514) 331-7440 ext 232
stephen@intelgenx.com
Or
Andre Godin, CPA, CA
Executive Vice-President and CFO
IntelGenx Corp.
(514) 331-7440 ext 203
andre@intelgenx.com
Intelgenx Technologies (TSXV:IGX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intelgenx Technologies (TSXV:IGX)
Historical Stock Chart
From Sep 2023 to Sep 2024